RCGP Curriculum - 15.8 Respiratory Problems
This section of our curriculum guide refers to statement 15.8, Respiratory Problems, produced by the... Read more
However, GPs say draft wording of the deals is ‘unacceptable’ because they allow PCTs to cancel contracts with suppliers without consulting practices that use those IT systems.
Under the national programme for IT, England is split into five regions, each overseen by an LSP.
Until earlier this year it appeared that the national IT programme would force practices to choose an IT system from a limited range of providers holding a contract with their LSP. But in March, Connecting for Health announced that GPs would be able to choose any system contracted to any of the five LSPs by April 2007.
The move allayed fears that the more than 50 per cent of practices in England that use the EMIS system could be forced to abandon it, because EMIS simultaneously signed a supply contract with CSC, the LSP for the North West and West Midlands.
But a Connecting for Health spokesman said last week: ‘In order to keep the exercise of choice simple, and to ensure value for money, it is intended to replace the numerous different contracting mechanisms that are currently used with a framework contract between the DoH and suppliers.’
Dr Paul Cundy, chairman of the joint GPC and RCGP IT committee said: ‘GPs will be able to choose the system they want from a central list.’
Quick search - use * for an abbreviated search, eg nico*
This section of our curriculum guide refers to statement 15.8, Respiratory Problems, produced by the... Read more
This section of our curriculum guide refers to statement 15.10, Skin Problems, produced by the Royal... Read more
This section of our curriculum guide refers to statement 13, Care of People with Mental Health Probl... Read more
Contributed by Dr Naila Arebi, consultant gastroenterologist, St Mark's Hospital, Harrow, and The Lo... Read more
Contributed by Dr Alan McOwan, lead clinician, Victoria Clinic for HIV and Sexual Health, London. Read more
A non-daily, low oestrogen contraceptive utilising a vaginal delivery system. Read more
Nordic Pharma has launched Siklos (hydroxycarbamide) for the prevention of recurrent painful vaso-oc... Read more
Schering-Plough has launched Bridion (sugammadex) for the reversal of neuromuscular blockade induced... Read more
Comments
Only registered users may comment. Log in now or register for a free account.